Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
KH-903 by Chengdu Kanghong Pharmaceuticals Group for Metastatic Colorectal Cancer: Likelihood of Approval
KH-903 is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase II for Metastatic Colorectal Cancer. According...